Healthcare -
Biotechnology - NASDAQ - US
$ 14.7
4.33 %
$ 1.67 B
Market Cap
-3.88
P/E
DYN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DYN - Dyne Therapeutics, Inc.
810 M
LAST VALUE
365.41%
2 YEAR CAGR
109.67%
5 YEAR CAGR
-16.98%
10 YEAR CAGR